The frequency of Muir-Torre syndrome among Lynch syndrome families - PubMed (original) (raw)
Comparative Study
. 2008 Feb 20;100(4):277-81.
doi: 10.1093/jnci/djm291. Epub 2008 Feb 12.
Affiliations
- PMID: 18270343
- DOI: 10.1093/jnci/djm291
Comparative Study
The frequency of Muir-Torre syndrome among Lynch syndrome families
Christopher D South et al. J Natl Cancer Inst. 2008.
Abstract
Lynch syndrome is the predisposition to visceral malignancies that are associated with deleterious germline mutations in DNA mismatch repair genes, including MLH1, MSH2, MSH6, and PMS2. Muir-Torre syndrome is a variant of Lynch syndrome that includes a predisposition to certain skin tumors. We determined the frequency of Muir-Torre syndrome among 50 Lynch syndrome families that were ascertained from a population-based series of cancer patients who were newly diagnosed with colorectal or endometrial carcinoma. Histories of Muir-Torre syndrome-associated skin tumors were documented during counseling of family members. Muir-Torre syndrome was observed in 14 (28%) of 50 families and in 14 (9.2%) of 152 individuals with Lynch syndrome. Four (44%) of nine families with MLH1 mutations had a member with Muir-Torre syndrome compared with 10 (42%) of 24 families with MSH2 mutations (P = .302). Families who carried the c.942+3A>T MSH2 gene mutation had a higher frequency of Muir-Torre syndrome than families who carried other mutations in the MSH2 gene (75% vs 25%; P = .026). Muir-Torre syndrome was not found in families with mutations in the MSH6 or PMS2 genes. Our results suggest that Muir-Torre syndrome is simply a variant of Lynch syndrome. Screening for Muir-Torre syndrome-associated skin lesions among patients with Lynch syndrome is recommended.
Similar articles
- A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome.
Perera S, Ramyar L, Mitri A, Pollett A, Gallinger S, Speevak MD, Aronson M, Bapat B. Perera S, et al. J Hum Genet. 2010 Jan;55(1):37-41. doi: 10.1038/jhg.2009.119. Epub 2009 Nov 13. J Hum Genet. 2010. PMID: 19911012 - Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
Ponti G, Manfredini M, Tomasi A, Pellacani G. Ponti G, et al. Gene. 2016 Sep 10;589(2):127-32. doi: 10.1016/j.gene.2015.06.078. Epub 2015 Jul 2. Gene. 2016. PMID: 26143115 Review. - [Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis].
Doré MX, Dieumegard B, Grandjouan S, Avril MF, Martinet C, Ducreux M, Lasser P, Bressac-de Paillerets B. Doré MX, et al. Ann Dermatol Venereol. 1999 Aug-Sep;126(8-9):582-6. Ann Dermatol Venereol. 1999. PMID: 10530344 French. - The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC.
Ollila S, Fitzpatrick R, Sarantaus L, Kariola R, Ambus I, Velsher L, Hsieh E, Andersen MK, Raevaara TE, Gerdes AM, Mangold E, Peltomäki P, Lynch HT, Nyström M. Ollila S, et al. Int J Oncol. 2006 Jan;28(1):149-53. Int J Oncol. 2006. PMID: 16327991 - The genetics of HNPCC: application to diagnosis and screening.
Abdel-Rahman WM, Mecklin JP, Peltomäki P. Abdel-Rahman WM, et al. Crit Rev Oncol Hematol. 2006 Jun;58(3):208-20. doi: 10.1016/j.critrevonc.2005.11.001. Epub 2006 Jan 23. Crit Rev Oncol Hematol. 2006. PMID: 16434208 Review.
Cited by
- Identification of patients at risk for hereditary colorectal cancer.
Mishra N, Hall J. Mishra N, et al. Clin Colon Rectal Surg. 2012 Jun;25(2):67-82. doi: 10.1055/s-0032-1313777. Clin Colon Rectal Surg. 2012. PMID: 23730221 Free PMC article. - ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW; American College of Gastroenterology. Syngal S, et al. Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263. doi: 10.1038/ajg.2014.435. Epub 2015 Feb 3. Am J Gastroenterol. 2015. PMID: 25645574 Free PMC article. Review. - Muir-Torre syndrome in Fitzpatrick skin phototype V assessed by dermoscopy and reflectance confocal microscopy.
Orloff J, Cabral P, Zhou L, Piontkowski AJ, Powers CM, Niedt G, Farnetani F, Gulati N. Orloff J, et al. Skin Res Technol. 2024 Aug;30(8):e13825. doi: 10.1111/srt.13825. Skin Res Technol. 2024. PMID: 39140293 Free PMC article. No abstract available. - Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.
Weissman SM, Bellcross C, Bittner CC, Freivogel ME, Haidle JL, Kaurah P, Leininger A, Palaniappan S, Steenblock K, Vu TM, Daniels MS. Weissman SM, et al. J Genet Couns. 2011 Feb;20(1):5-19. doi: 10.1007/s10897-010-9325-x. Epub 2010 Oct 8. J Genet Couns. 2011. PMID: 20931355 Review. - The genetic basis of Lynch syndrome and its implications for clinical practice and risk management.
Cohen SA, Leininger A. Cohen SA, et al. Appl Clin Genet. 2014 Jul 22;7:147-58. doi: 10.2147/TACG.S51483. eCollection 2014. Appl Clin Genet. 2014. PMID: 25161364 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous